Identification of phosphorylation sites on the E3 ubiquitin ligase UBR5/EDD

Journal of Proteomics

Volumn 75, Issue 2, 2011, Pages 603-609

  Bethard, Jennifer Rutherford ^a   Zheng, Hui ^a   Roberts, Lawton ^a   Eblen, Scott T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Collision induced dissociation mass spectrometry; EDD; LC MS MS; Phosphorylation; Ubiquitin ligase; UBR5

Indexed keywords

BIOLOGICAL MARKER; E3 LIGASE IDENTIFIED BY DIFFERENTIAL; PHOSPHOPROTEIN; PLATINUM; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DISSOCIATION MASS SPECTROMETRY; DNA DAMAGE; ENZYME ISOLATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, LIQUID; COS CELLS; PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; UBIQUITIN-PROTEIN LIGASES;

EID: 82355192264     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.08.023     Document Type: Article

References (27)

1. Baumeister W., Walz J., Zuhl F., Seemuller E. The proteasome: paradigm of a self-compartmentalizing protease. Cell 1998, 92(3):367-380.
2. Callaghan M.J., Russell A.J., Woollatt E., Sutherland G.R., Sutherland R.L., Watts C.K. Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene 1998, 17(26):3479-3491.
3. Henderson M.J., Russell A.J., Hird S., Munoz M., Clancy J.L., Lehrbach G.M., et al. EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response. J Biol Chem 2002, 277(29):26468-26478.
4. Clancy J.L., Henderson M.J., Russell A.J., Anderson D.W., Bova R.J., Campbell I.G., et al. EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer. Oncogene 2003, 22(32):5070-5081.
5. Fuja T.J., Lin F., Osann K.E., Bryant P.J. Somatic mutations and altered expression of the candidate tumor suppressors CSNK1 epsilon, DLG1, and EDD/hHYD in mammary ductal carcinoma. Cancer Res 2004, 64(3):942-951.
6. O'Brien P.M., Davies M.J., Scurry J.P., Smith A.N., Barton C.A., Henderson M.J., et al. The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro. Br J Cancer 2008, 98(6):1085-1093.
7. Munoz M.A., Saunders D.N., Henderson M.J., Clancy J.L., Russell A.J., Lehrbach G., et al. The E3 ubiquitin ligase EDD regulates S-phase and G(2)/M DNA damage checkpoints. Cell Cycle 2007, 6(24):3070-3077.
8. Henderson M.J., Munoz M.A., Saunders D.N., Clancy J.L., Russell A.J., Williams B., et al. EDD mediates DNA damage-induced activation of CHK2. J Biol Chem 2006, 281(52):39990-40000.
9. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., et al. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 2010, 3:104.
10. Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K., et al. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2009, 2:84.
11. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., et al. A quantitative atlas of mitotic phosphorylation. Proceedings of the National Academy of Science U S A 2008, 105:10762-10767. 31.
12. Nousiainen M., Sillje H.H., Sauer G., Nigg E.A., Korner R. Phosphoproteome analysis of the human mitotic spindle. Proceedings of the National Academy of Science U S A 2006, 103:5391-5396. 14.
13. Chen R.Q., Yang Q.K., Lu B.W., Yi W., Cantin G., Chen Y.L., et al. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res 2009, 69(6):2663-2668.
14. Sui S., Wang J., Yang B., Song L., Zhang J., Chen M., et al. Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy. Proteomics 2008, 8(10):2024-2034.
15. Choudhary C., Olsen J.V., Brandts C., Cox J., Reddy P.N., Bohmer F.D., et al. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes. Mol Cell 2009, 36(2):326-339.
16. Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., et al. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol Cell 2008, 31(3):438-448.
17. Han G., Ye M., Liu H., Song C., Sun D., Wu Y., et al. Phosphoproteome analysis of human liver tissue by long-gradient nanoflow LC coupled with multiple stage MS analysis. Electrophoresis 2010, 31(6):1080-1089.
18. Malik R., Lenobel R., Santamaria A., Ries A., Nigg E.A., Korner R. Quantitative analysis of the human spindle phosphoproteome at distinct mitotic stages. J Proteome Res 2009, 8(10):4553-4563.
19. Van Hoof D., Munoz J., Braam S.R., Pinkse M.W., Linding R., Heck A.J., et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009, 5(2):214-226.
20. Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., et al. Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 2009, 8(7):1751-1764.
21. Eblen S.T., Kumar N.V., Shah K., Henderson M.J., Watts C.K., Shokat K.M., et al. Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J Biol Chem 2003, 278(17):14926-14935.
22. Kimelman D., Xu W. Beta-catenin destruction complex: insights and questions from a structural perspective. Oncogene 2006, 25(57):7482-7491.
23. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16(13):3797-3804.
24. Hay-Koren A., Caspi M., Zilberberg A., Rosin-Arbesfeld R. The EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin. Mol Biol Cell 2011, 22(3):399-411.
25. Mu J.J., Wang Y., Luo H., Leng M., Zhang J., Yang T. A proteomic analysis of ataxia telangiectasia-mutated (ATM)/ATM-Rad3-related (ATR) substrates identifies the ubiquitin-proteasome system as a regulator for DNA damage checkpoints. J Biol Chem 2007, 282(24):17330-17334.
26. Hunter T., Sefton B.M. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proceedings of the National Academy of Science U S A 1980, 77:1311-1315. 3.
27. Cooper J.A., Hunter T. Regulation of cell growth and transformation by tyrosine-specific protein kinases: the search for important cellular substrate proteins. Curr Top Microbiol Immunol 1983, 107:125-161.